Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.85 |
| ▸ | LPL | P06858 | 12/20 | 0.85 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15678312 | 1.00 | LIPG (0.85) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL14506127 | 0.98 | LIPG (0.88) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL431713 | 0.98 | LIPG (0.88) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL31139946 | 0.98 | LIPG (0.88) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL27254683 | 0.94 | LIPG (0.80) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL27254410 | 0.94 | LIPG (0.80) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL24377079 | 0.94 | LIPG (0.80) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL31667850 | 0.92 | LIPG (0.77) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL25799121 | 0.92 | LIPG (0.77) | LIPGLPLESR1ESR2DGAT1 | |
| SCHEMBL15197479 | 0.92 | LIPG (1.00) | LIPGLPLESR1ESR2SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10035765-B2 | Nitrogen-containing polycyclic compound and organic light emitting device using same | LG CHEM, LTD. (KR) | 2018-07-31 | — | — | US | disclosed |
| US-10035765-B2 | Nitrogen-containing polycyclic compound and organic light emitting device using same | LG CHEM, LTD. (KR) | 2018-07-31 | — | — | US | disclosed |
| US-20170283379-A1 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME (AS AMENDED) | LG CHEM, LTD. (KR) | 2017-10-05 | — | — | US | disclosed |
| US-20170283379-A1 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME (AS AMENDED) | LG CHEM, LTD. (KR) | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170283379-A1 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME (AS AMENDED) | PER2, CRY1, CRY2 | LIPG 4223/4885LPL 3762/4885ESR1 379/4885 |
| US-10035765-B2 | Nitrogen-containing polycyclic compound and organic light emitting device using same | NPM1, PER2, CRY1 | LIPG 4116/4885LPL 3876/4885ESR1 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.